The DOI matches its Crossref record.
Copper Compounds in Cancer Chemotherapy
Abstract
Transitional metals have a large variety of coordination numbers and geometries, accessible redox states in physiological conditions and a wide range of thermodynamic and reactivity properties which can be successfully tuned by selection of suitable ligands. These characteristics can be used to develop new drugs with numerous advantages over the organic based drugs. Historically, research in this field has focus on platinum and DNA targeting; however, anticancer drug research may be expanded to include alternative metal compounds with different mode of action resulting in markedly different cytotoxic response profiles. Copper complexes with selected ligands are being extensively studied as agents for the treatment of cancer. Current research on copper compounds as antitumoral compounds is being reviewed in this chapter particularly focused on the family of copper Casiopeinas. Keywords: Copper compounds, drugs, medicinal inorganic chemistry, Cancer Chemotherapy, organic based drugs, geometries, DNA targeting, copper Casiopeinas, low hydrosolubility, cisplatin (CDDP), therapeutic potential, tumor cell growth, cell proliferation, antitumor agents, Casiopeínas®, Pt clinical drugs, Carboplatino, Oxalilplatino, Nedaplatino, Lobaplatino, Cu (II) thiosemicarbazidecomplexes, Isatin-Schiff base copper (II), platinum-based drugs, ascorbate oxidase, tyrosinase, copper-biological molecules, Wilson disease (WD), Menkes disease (MD), thiosemicarbazone complexes, imidazole, benzimidazole, phenanthroline, bipyridine complexes, antiproliferative activity, Casiopeína II-gly, Casiopeína III-ia, phenanthrolines, L-amino acidate, mixed-ligand complexes, phenanthroline basicity, Structure-Activity Relationships, cytostatic, genotoxic, antitumor activi-ties, diimine ligand, murine glioma, genotoxic activity, Melanoma B16, Leukemia L1210, medulloblastoma, glutathione depletion, hemolytic anemia, Cytotoxicity, hematological effects, cardiovascular toxicity, antineoplastic drug, cisplatin therapy, copper-based antitumor agents, metal, –, ligand combination, recognition of target sites
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Role of Copper on Mitochondrial Function and Metabolism
Ruiz, L. M., Libedinsky, A., & Elorza, A. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.711227 · Cited by 564
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Zhang, J., Duan, D., Song, Z., Liu, T., Hou, Y., & Fang, J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21734 · Cited by 184
Metadata
- Authors
- Ruiz-Azuara, L., & E. Bravo-Gomez, M.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-11-01
- Volume
- 17
- Issue
- 31
- Pages
- 3606-3615
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2040527477
- Cited by
- 253
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Copper Compounds in Cancer Chemotherapy. https://app.cochat.ai/papers/10.2174/092986710793213751
- The paper
- Ruiz-Azuara, L., & E. Bravo-Gomez, M. (2010). Copper Compounds in Cancer Chemotherapy. Current Medicinal Chemistry. https://doi.org/10.2174/092986710793213751
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.